Harvard study – Exclusive market rights encouraging high drug prices
In a remarkable Harvard Study, the key reasons behind the high drug prices in the United States (US) have been […]
Say something
Tags: Aaron Kesselheim, Ameet Sarpatwari, Engelberg Foundation, Food and Drugs Administration, Generic drug, Harvard, Harvard Study, JAMA, Jerry Avorn, John Arnold Foundation, medicaid, Monopoly, Pharma Companies, Prescription drug, research and development, the Journal of the American Medical Association, United States
Real costs of R& D decoded
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
-
-
Flipkart Health+ App Launched
06-04-2022
